Navigation Links
Palatin Technologies Receives Non-Compliance Letter from NYSE Amex
Date:12/2/2010

CRANBURY, N.J., Dec. 2, 2010 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) today reported it received notice from NYSE Amex LLC (the "Exchange"), advising Palatin that it is not in compliance with certain conditions of the Exchange's continued listing standards under Section 1003 of the Exchange's Company Guide.

In a letter to Palatin, the Exchange stated that Palatin was not in compliance with Section 1003(a)(iii) of the Company Guide because Palatin's stockholders' equity is less than the required $6,000,000 and Palatin has losses from continuing operations and net losses in its five most recent fiscal years, and not in compliance with Section 1003(a)(iv) of the Company Guide because Palatin has sustained losses which are so substantial in relation to its overall operations or existing financial resources, or its financial condition has become so impaired that it appears questionable, in the opinion of the Exchange, as to whether Palatin will be able to continue operations and/or meet its obligations as they mature.

Palatin intends to submit a plan of compliance by December 27, 2010, advising the Exchange how it intends to regain compliance with Section 1003(a)(iv) by February 28, 2011 and Section 1003(a)(iii) by May 26, 2011.  If the Exchange accepts the plan, Palatin may be able to continue its listing during the plan period, subject to periodic review to determine if Palatin is making progress consistent with the plan. If Palatin does not submit a plan, or if the Exchange does not accept the plan, or if Palatin does not regain compliance within the applicable deadlines, or if Palatin does not make progress consistent with the plan during the plan period, the Exchange may initiate delisting procedures.

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company dedicated to the development
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
2. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
3. Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994
4. Palatin Technologies Presents PL-3994 Clinical Trial Results at the 12th Annual Scientific Meeting of the Heart Failure Association of America
5. Palatin Technologies to Present at 8th Annual BIO Investor Forum
6. Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men
7. Palatin Technologies, Inc. To Raise $2.6 Million Dollars in Registered Direct Offering
8. Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca
9. Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men
10. Palatin Technologies to Present at Rodman & Renshaw Annual Global Investment Conference
11. Palatin Technologies to Present at 9th Annual BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014 The Parenteral Drug Association (PDA) ... post-approval changes protocols. The new initiative ... expressed by industry participants and regulatory authority representatives at ... in Washington, DC . Representatives of ... for the workshop. Attendees indicated openness to engaging regulators ...
(Date:9/19/2014)... Research and Markets ... of the "Global Gynecological Devices Market ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... wide categories based on their operations. These ... different gynecological conditions that affect the female ...
(Date:9/19/2014)... RESEARCH TRIANGLE PARK, N.C. , Sept. 19, ... company focused on cloud-based drug design and development, ... strategy. The company,s mission is to design new ... Phase 1 and 2 partners to further their ... enhance its portfolio investments. To support this business ...
Breaking Medicine Technology:PDA Launches Effort to Harmonize Global Post-Approval Changes Protocols 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 3Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 2
... NEW YORK, Dec. 8, 2010 Reportlinker.com announces that ... catalogue: China Pharmaceutical Market Overview ... IntroductionThe Chinese hospital prescription pharma market generated sales of ... of 26.5% between 2008 and 2009. Key growth drivers ...
... Reportlinker.com announces that a new market research ... Russia Pharmaceutical Market Overview Pharma ... presents http://www.reportlinker.com/p0337454/Russia-Pharmaceutical-Market-Overview---Pharma-companies-target-Russia-despite-the-challenges-it-presents.html ... generated $10.1 billion in sales in 2009, ...
Cached Medicine Technology:Reportlinker Adds China Pharmaceutical Market Overview 2Reportlinker Adds China Pharmaceutical Market Overview 3Reportlinker Adds China Pharmaceutical Market Overview 4Reportlinker Adds China Pharmaceutical Market Overview 5Reportlinker Adds China Pharmaceutical Market Overview 6Reportlinker Adds China Pharmaceutical Market Overview 7Reportlinker Adds China Pharmaceutical Market Overview 8Reportlinker Adds China Pharmaceutical Market Overview 9Reportlinker Adds China Pharmaceutical Market Overview 10Reportlinker Adds China Pharmaceutical Market Overview 11Reportlinker Adds China Pharmaceutical Market Overview 12Reportlinker Adds China Pharmaceutical Market Overview 13Reportlinker Adds China Pharmaceutical Market Overview 14Reportlinker Adds China Pharmaceutical Market Overview 15Reportlinker Adds China Pharmaceutical Market Overview 16Reportlinker Adds China Pharmaceutical Market Overview 17Reportlinker Adds Russia Pharmaceutical Market Overview Pharma Companies Target Russia Despite the Challenges it Presents 2Reportlinker Adds Russia Pharmaceutical Market Overview Pharma Companies Target Russia Despite the Challenges it Presents 3Reportlinker Adds Russia Pharmaceutical Market Overview Pharma Companies Target Russia Despite the Challenges it Presents 4Reportlinker Adds Russia Pharmaceutical Market Overview Pharma Companies Target Russia Despite the Challenges it Presents 5Reportlinker Adds Russia Pharmaceutical Market Overview Pharma Companies Target Russia Despite the Challenges it Presents 6Reportlinker Adds Russia Pharmaceutical Market Overview Pharma Companies Target Russia Despite the Challenges it Presents 7Reportlinker Adds Russia Pharmaceutical Market Overview Pharma Companies Target Russia Despite the Challenges it Presents 8Reportlinker Adds Russia Pharmaceutical Market Overview Pharma Companies Target Russia Despite the Challenges it Presents 9Reportlinker Adds Russia Pharmaceutical Market Overview Pharma Companies Target Russia Despite the Challenges it Presents 10Reportlinker Adds Russia Pharmaceutical Market Overview Pharma Companies Target Russia Despite the Challenges it Presents 11Reportlinker Adds Russia Pharmaceutical Market Overview Pharma Companies Target Russia Despite the Challenges it Presents 12Reportlinker Adds Russia Pharmaceutical Market Overview Pharma Companies Target Russia Despite the Challenges it Presents 13Reportlinker Adds Russia Pharmaceutical Market Overview Pharma Companies Target Russia Despite the Challenges it Presents 14
(Date:9/21/2014)... C8 lawsuits move forward in the U.S. District ... 20 possible C8 lawsuits selected for bellwether trials ... & Schulte LLC. Court records show these six C8 ... filed that represent individuals who purportedly developed kidney cancer, ... being exposed to water contaminated by the C8 chemical ...
(Date:9/21/2014)... 21, 2014 Top10BestSEOHosting.com, a leading ... ) and GreenGeeks are the most recommended hosting ... buy high quality hosting products. , “Don’t ... suppliers; we recommend two great hosting companies to ... believe that iPage and GreenGeeks are the most ...
(Date:9/20/2014)... 21, 2014 Recently, UWDress.com, a professional ... a promotion for its newly announced evening cocktail ... the company’s special occasion outfits are very popular among ... provided with big savings (up to 65 percent off). ... offer more fashionable special occasion outfits for the global ...
(Date:9/20/2014)... 2014 Weight Destroyer , a ... expert Michael Wren that has already helped tens of ... health conditions like high blood pressure, high cholesterol, and ... prompting an investigative review. , “Weight Destroyer is ... down by showing people what is truly effective when ...
(Date:9/20/2014)... 20, 2014 David Cooke presented two ... first poster looked at the clinical benefits of MPI ... calculating diastolic function. In conjunction with colleagues at Emory ... and normal LVEF by echo (>50%). Each patient had ... standard SPECT. Emory Toolbox 4.0 was used ...
Breaking Medicine News(10 mins):Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 3Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 4Health News:Leading Review Website Top10BestSEOHosting.com Unveils The Best Hosting Suppliers In September 2Health News:Cheap Evening Cocktail Dresses Recently Introduced At UWDress.com 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 3Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 3
... rates reach the highest levels in 16 years, a ... laid-off workersonly 9 percenttook up coverage under the Consolidated ... who also lose their health insurance would need substantial ... health insurance premiums, for their premium contributions to remain ...
... Incidents were reported by half of family caretakers surveyed in ... than half of family members looking after people with dementia ... British study finds. , Actual physical abuse was rare, being ... study. But the researchers, who published their findings in ...
... 22 The following is a statement from United ... Hearing Officer Ray Marshall ruled against a ... of the Service Employees International Union in 1921 that ... right to take over a local union. Even with ...
... T. Allison, FACHE, president/CEO of Baylor Health Care System ... the Texas Hospital Association,s Earl M. Collier Award for ... Award is the highest honor bestowed by THA. Allison ... Leadership Conference in Austin."Joel Allison exemplifies the leadership qualities ...
... MADISON, N.J., Jan. 22 At a meeting of its ... ) declared dividends on both the Common and Preferred Stock ... on the outstanding shares of Common Stock was declared payable ... close of business on February 13, 2009. In addition, ...
... WASHINGTON, Jan. 22 Speaker Nancy Pelosi released ... 36th Anniversary of Roe v. Wade:"On the 36th ... commitment to protecting a woman,s right to make ... just two days after swearing in a new ...
Cached Medicine News:Health News:Only about one of ten unemployed workers obtain COBRA coverage 2Health News:Many Alzheimer's Caregivers Admit to Abusive Behavior 2Health News:Many Alzheimer's Caregivers Admit to Abusive Behavior 3Health News:UHW Statement on Ray Marshall Trusteeship Recommendations 2Health News:Allison Honored with Hospital Association's Highest Award 2Health News:Allison Honored with Hospital Association's Highest Award 3
5 mm tying platform, serrated cross action handle with polished finish. Teeth: 0.10 mm, 1 x 2 set at 90 degrees....
5 mm tying platform, serrated cross action handle with polished finish. Teeth: 0.10 mm, 1 x 2 set at 45 degrees....
6 mm tying platform. Round knurled handle with polished finish. Teeth: 0.3 mm, 1 x 2. Orientation: Left hand....
0.12 mm, 1 x 2 teeth set at 45 degrees with 6 mm tying platform. Wide serrated handle with polished finish....
Medicine Products: